Off-label use of recombinant factor VIIa (rFVIIa) for postoperative hematuria in a factor VII deficient renal transplant patient.

被引：0
|
作者：
Gloster, E
Strauss, R
DaCosta, M
Essex, D
Distant, D
Braverman, A
机构：
[1] SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA
[2] NYU, Sch Med, New York, NY USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4037
引用
收藏
页码：82B / 83B
页数：2
相关论文
共 50 条
  • [31] Off label use of recombinant factor viia in the hematology ward
    Rajic, N., V
    Rajic, N., V
    Popovic, S.
    Savic, A.
    Savic, I
    Urosevic, I
    Zeravica, B.
    Vlaisavljevic, N.
    Agic, D.
    Percic, I
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 856 - 856
  • [32] Off-label use of recombinant factor VIIa: why we need better drug monitoring
    Hebert, Paul C.
    Fergusson, Dean
    Stanbrook, Matthew B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (01) : 26 - 27
  • [33] Off-Label Use of Recombinant Factor VIIa in United States Hospitals: 2000-2008
    Logan, Aaron C.
    Yank, Veronica
    Stafford, Randall S.
    BLOOD, 2009, 114 (22) : 33 - 34
  • [34] Successful outcome of a cirrhotic patient with postoperative hematuria treated with a high single dose of recombinant activated factor VII (rFVIIa).
    Lucia, JF
    Orna, E
    Allepuz, C
    Aguilar, C
    Giralt, M
    Carrasco, V
    Lopez, L
    Simon, MA
    BLOOD, 2001, 98 (11) : 82B - 82B
  • [35] Prophylactic effect of recombinant factor VIIa in factor VII deficient patients
    Mathijssen, NCJ
    Masereeuw, RS
    Verbeek, K
    Lavergne, JM
    Costa, JM
    van Heerde, WL
    Nováková, IRO
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 (04) : 494 - 499
  • [36] Review of the Off-Label Use of Recombinant Activated Factor VII in Pediatric Cardiac Surgery Patients
    Guzzetta, Nina A.
    Russell, Isobel A.
    Williams, Glyn D.
    ANESTHESIA AND ANALGESIA, 2012, 115 (02): : 364 - 378
  • [37] Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery
    Karkouti, Keyvan
    Beattie, W. Scott
    Arellano, Ramiro
    Aye, Tim
    Bussieres, Jean S.
    Callum, Jeannie L.
    Cheng, Davy
    Heinrich, Lee
    Kent, Blaine
    Lee, Trevor W. R.
    MacAdams, Charles
    Mazer, C. David
    Muirhead, Brian
    Rochon, Antoine G.
    Rubens, Fraser D.
    Sawchuk, Corey
    Wang, Shaohua
    Waters, Terrence
    Wong, Bill I.
    Yau, Terrence M.
    CIRCULATION, 2008, 118 (04) : 331 - 338
  • [38] Off-label use of recombinant activated factor VII in hemophagocytic lymphohistiocytosis patients with major bleeding
    You, Yahong
    Suolitiken, Dina
    Wu, Lin
    Pi, Yubo
    Chen, Leilei
    Song, Deli
    Song, Zhengyang
    Wang, Zhao
    Wang, Jingshi
    LEUKEMIA & LYMPHOMA, 2025,
  • [39] A strategy for managing recombinant human Factor VIIa (NovoSeven®) off-label use in the academic hospital setting
    Harris, SB
    Lögdberg, LE
    TRANSFUSION, 2005, 45 (03) : 159A - 159A
  • [40] Systematic Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications
    Yank, Veronica
    Tuohy, C. Vaughan
    Logan, Aaron C.
    Bravata, Dena M.
    Staudenmayer, Kristan
    Eisenhut, Robin
    Sundaram, Vandana
    McMahon, Donal
    Olkin, Ingram
    McDonald, Kathryn M.
    Owens, Douglas K.
    Stafford, Randall S.
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (08) : 529 - 540
12345